Physician

Vivek Agarwal, M.D.

According to 2025 Medicare claims, Vivek Agarwal, M.D. (NPI: 1982918199) practices nephrology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (NPI: 1518589803; TIN: 850900392) and primary practice location at 45805-4602. Agarwal is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Agarwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 829 traditional Medicare patients, billed 3,204 HCPCS/CPT codes, and received $253,379 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,205 prescription claims across 548 beneficiaries totaling $327,069 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2020 DME data shows 12 claims. Open Payments data shows 4 records totaling $170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $31,817 to $327,069. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	630	2,716	$187,809
2016	698	2,972	$192,005
2017	727	2,829	$189,050
2018	775	2,863	$206,232
2019	804	3,455	$252,503
2020	812	3,212	$250,584
2021	740	3,077	$257,500
2022	801	3,109	$256,928
2023	829	3,085	$259,822
2024	829	3,204	$253,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	153	1,125	$31,817
2016	188	1,407	$35,947
2017	207	1,690	$65,295
2018	267	1,627	$144,440
2019	299	1,856	$227,993
2020	317	1,987	$239,212
2021	352	2,067	$245,447
2022	409	2,374	$305,112
2023	478	2,795	$292,857
2024	548	3,205	$327,069

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	39	$830
2020	N/R	12	$1,189
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	103	103	$104
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	167	225	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	154	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	272	1,269	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	486	665	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	53	2,130	$131,364
Lokelma	Sodium Zirconium Cyclosilicate	50	2,044	$38,758
Farxiga	Dapagliflozin Propanediol	25	1,470	$26,469
Fosrenol	Lanthanum Carbonate	21	630	$25,738
Veltassa	Patiromer Calcium Sorbitex	18	533	$17,994

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$170	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vivek Agarwal, M.D.?

Tedicare shows public-source Medicare data for Vivek Agarwal, M.D. (NPI 1982918199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vivek Agarwal, M.D. have ACO affiliation data?

Vivek Agarwal, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Vivek Agarwal, M.D.?

Vivek Agarwal, M.D. is linked to MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (billing NPI 1518589803) in the available physician profile data.

Does Vivek Agarwal, M.D. have Open Payments data?

Vivek Agarwal, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.